BRAINTECH INC·4

Jan 29, 7:37 PM ET

BRAINTECH INC 4

4 · BRAINTECH INC · Filed Jan 29, 2010

Insider Transaction Report

Form 4
Period: 2009-12-17
SPEROS JAMES
Director
Transactions
  • Award

    OPTIONS

    2009-12-17+2,062,5003,334,500 total
    Exercise: $0.05From: 2009-12-17Exp: 2019-12-16COMMON (2,062,500 underlying)
  • Other

    WARRANTS

    2010-01-26+625,0001,187,500 total(indirect: BY CORPORATION)
    Exercise: $0.30From: 2008-09-26Exp: 2013-09-26COMMON (625,000 underlying)
  • Other

    COMMON STOCK

    2010-01-26+250,000830,000 total
Holdings
  • WARRANTS

    Exercise: $0.50From: 2007-12-29Exp: 2009-12-29COMMON (62,500 underlying)
    62,500
  • WARRANTS

    Exercise: $0.50From: 2005-03-04Exp: 2010-03-03COMMON (48,750 underlying)
    111,250
  • WARRANTS

    (indirect: BY CORPORATION)
    Exercise: $0.30From: 2006-10-23Exp: 2011-10-23COMMON (375,000 underlying)
    375,000
  • WARRANTS

    (indirect: BY CORPORATION)
    Exercise: $0.50From: 2006-10-23Exp: 2011-10-23COMMON (187,500 underlying)
    562,500
  • OPTIONS

    Exercise: $0.20From: 2002-12-02Exp: 2008-12-01COMMON (50,000 underlying)
    50,000
  • OPTIONS

    Exercise: $0.65From: 2005-07-25Exp: 2010-01-24COMMON (100,000 underlying)
    150,000
  • OPTIONS

    Exercise: $0.66From: 2005-02-10Exp: 2010-02-09COMMON (47,000 underlying)
    197,000
  • OPTIONS

    Exercise: $0.36From: 2007-03-22Exp: 2012-03-22COMMON (750,000 underlying)
    1,172,000
  • OPTIONS

    Exercise: $0.22From: 2008-09-26Exp: 2013-09-26COMMON (100,000 underlying)
    1,272,000
Footnotes (2)
  • [F1]In October 2006, Mr. Speros provided a US$125,000 guarantee to secure a bank loan for the Company. In September 2008 Mr. Speros agreed to extend the loan guarantee. As compensation for extending the loan guarantee, the Company agreed that, for each dollar of loan guarantee provided, it would issue two (2) shares of common stock of the Company and five (5) share purchase warrants. Each share purchase warrant entitles the holder to purchase one (1) additional share of the common stock of the Company at a price of $0.30 per share for a period of five (5) years.
  • [F2]These options were issued in lieu of accrued directors fees payable and are exercisable as of December 17, 2009.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4